Medipixel
A global healthcare company improving the quality of human life by applying AI technology to healthcare.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | KRW17.0b | Series B | |
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 40 % | 200 % | 205 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Medipixel is a global healthcare company leveraging artificial intelligence (AI) to enhance the quality of human life. Specializing in the development of Software as a Medical Device (SaMD), Medipixel's core product, MPXA, integrates seamlessly into the cath lab workflow. This cutting-edge software utilizes deep learning technology to automatically analyze patients' cardiovascular conditions in real time, providing quick and accurate support for clinicians' decision-making processes. Medipixel primarily serves healthcare providers and operates within the digital health market. The company's business model revolves around the sale and licensing of its AI-driven software solutions, generating revenue through direct sales, subscriptions, and partnerships with medical institutions.
Keywords: AI, healthcare, cardiovascular, diagnostics, SaMD, deep learning, real-time analysis, decision support, digital health, medical software.